Certara, Inc. (CERT) Dividend History

Company News

• 10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential

  Several healthcare and AI-driven companies are demonstrating significant potential in transforming medical technologies, offering innovative therapies and solutions across various medical domains like gene editing, telehealth, and precision medicine.

  The Motley Fool

  Featured Companies: BEAM INSP KRYS LFMD LFMDP PODD TEM TMDX VEEV
• 3 Momentum Stocks That Could Soar Post-Market Volatility

  Three companies in the software-based drug development and furniture industries have emerged as momentum plays following a period of market volatility. Certara, Schrodinger, and Lovesac have seen their stock prices rise significantly due to positive news, technological advancements, and adaptable business models.

  Investing.com

  Featured Companies: LOVE SDGR
• These Mid-Cap Stocks Outshone The Market Volatility Last Week (Apr 7-Apr 11): Are These In Your Portfolio?

  Several mid-cap stocks outperformed the market during the volatile week of April 7-11, including AeroVironment, Recursion Pharmaceuticals, Certara, and Agilon Health. The gains were driven by factors such as FDA reforms, tariff pauses, and positive news for the companies.

  Benzinga

  Featured Companies: AGL AVAV RXRX
• Biosimulation Industry Forecast, 2029: Analysis of Case Studies, Market Dynamics, Regional Growth Trends, Regulatory Landscape, Value Chain, and Competitive Intelligence

  The biosimulation market is projected to reach USD 9.18 billion by 2029, growing at a CAGR of 16.7% from 2024 to 2029. The market is driven by the increasing need for cost and time reduction in the drug development process, but high costs of biosimulation technologies remain a restraint.

  GlobeNewswire Inc.

  Featured Companies: ANSS SDGR SLP
• Certara, Inc. (CERT) Q1 Earnings Meet Estimates

  Certara (CERT) delivered earnings and revenue surprises of 0% and 2.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: XOMA